🔎 Trials Near Me

Home › Peripheral Arterial Disease › NCT07313410

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

RecruitingObservational studyHealthy volunteers welcome

Near-Infrared Diffuse Correlation Spectroscopy to Better Define the Pathophysiology of Peripheral Artery Disease

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Cases, Aim 1

  1. 18 or older
  2. willing to participate under the conditions described in the informed consent form (ICF)
  3. eligible to sign the ICF
  4. established diagnosis of PAD confirmed by a physician
  5. able to comply with the study requirements
* Cases, Aim 2

  1\) completed Aim 1
* Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease

Exclusion Criteria:

* Cases, Aim 1

  1. Ankle-Brachial Index \>0.9 or \<0.4
  2. isolated disease in aorta/iliac vessels
  3. unstable angina or myocardial infarction in past 12 months
  4. orthopedic or other physical limitations which would prevent data collection
  5. contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator
* Cases, Aim 2

  1. unstable angina or myocardial infarction in past 12 months
  2. orthopedic or other physical limitations which would prevent data collection
  3. contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
* Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP \>150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).

About the study

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes.

Specific aims include:

Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction.

Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Sponsor: The University of Texas at Arlington · Participants: 120 · Started: Nov 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07313410

Locations in the U.S.

TexasUniversity of Texas Arlington, Arlington (Not yet recruiting)
University of Texas at Arlington, Arlington

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.